Clinical Trial Update: Long-term Pantoprazole Trial in Patients With Symptoms of Chronic Acid Peptic Complaints (BY1023/VMG-708) [Phase 3]

View source ↗

Summary

Phase 3 long-term trial of pantoprazole in patients with chronic acid-related symptoms (GERD and peptic ulcers) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease
• Peptic Ulcer Disease

Drugs mentioned

• Pantoprazole (pantoprazole)

Snippet

Sponsor: Takeda | Conditions: Gastroesophageal Reflux Disease (GERD), Peptic Ulcers | Phase 3 | Status: COMPLETED